Single Ascending Dose Study of RBP-7000

NCT02768649 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

45

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: RBP-7000
DRUG: risperidone

Sponsor

Indivior Inc.